Original insights, commentary, and expert analysis
The pharma field sees launches as key. Launches set brand paths. A high share of launches fail. Late fixes do
In today’s shifting health care, pharma firms join digital health. Innovation joins with partners. Success meets through linked work. Pharma
In today’s healthcare scene, pharma firms work with many groups. Each group has its own want. Each group holds one
In a world of drug tests, trials must show all lives. Experts meet. They say design must start with the
The pharmaceutical industry is always in flux, driven by innovation, competition, and the need for cost efficiencies. In October, significant
Duchenne muscular dystrophy harms boys. It makes muscles weak. It stops movement. It takes breaths. It ends lives in the
In recent years, the mounting pressure to lower drug prices has prompted significant changes in pharmaceutical pricing strategies. One of
The pharmaceutical landscape is witnessing significant changes with the recent implementation of the Inflation Reduction Act (IRA) and Novo Nordisk’s
In an era where convenience and efficiency dictate consumer preferences, General Medicine, a revolutionary healthcare startup founded by a team
Bayer’s recent Phase 3 clinical trial for its innovative blood-thinner, asundexian, has captured the attention of the medical community and
Bayer has recently made headlines in the biopharma sector with groundbreaking results from its Phase 3 clinical trial for asundexian,
Eli Lilly has cemented its place in pharmaceutical history by reaching an unprecedented market value of $1 trillion on November
AstraZeneca, the global biopharmaceutical giant, has recently made headlines with its ambitious plan to inject $2 billion into its manufacturing
Eli Lilly has made headlines by becoming the first pharmaceutical company in history to achieve a market capitalization of $1
As we navigate a world emerging from the pandemic, few companies exemplify resilience and adaptability in the biotechnology sector like
In recent months, the landscape of public health and vaccine adoption has undergone a dramatic transformation, coinciding with Robert F.
In an era where the resilience of healthcare systems has been tested like never before, leading biopharmaceutical companies Novartis and
In a world grappling with the aftermath of a pandemic, Moderna has adopted a bold financial strategy to navigate the
Agios Pharmaceuticals recently faced a tumultuous period as its stock value took a dramatic plunge following the mixed results from
Pfizer’s recent acquisition of Metsera marks a crucial step in the pharmaceutical giant’s strategy to address the rising global obesity